A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MITAPIVAT IN PATIENTS WITH SICKLE CELL DISEASE
a Division of Hematology, University of Toronto, Toronto, Canada
b Agios Pharmaceuticals, Inc., Cambridge, United States
c Van Creveldkliniek, Department of Internal Medicine, University Medical Center Utrecht, Utrecht, Netherlands
d Sickle Cell Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, United States
Read
1432
Timeswas read the article
630
Total PDF
802
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 May | 14 | 10 | 24 |
| 2025 April | 38 | 27 | 65 |
| 2025 March | 69 | 14 | 83 |
| 2025 February | 39 | 15 | 54 |
| 2025 January | 27 | 23 | 50 |
| 2024 December | 29 | 9 | 38 |
| 2024 November | 37 | 23 | 60 |
| 2024 October | 32 | 25 | 57 |
| 2024 September | 45 | 20 | 65 |
| 2024 August | 46 | 24 | 70 |
| 2024 July | 39 | 27 | 66 |
| 2024 June | 42 | 27 | 69 |
| 2024 May | 45 | 32 | 77 |
| 2024 April | 31 | 14 | 45 |
| 2024 March | 18 | 22 | 40 |
| 2024 February | 17 | 27 | 44 |
| 2024 January | 15 | 15 | 30 |
| 2023 December | 18 | 18 | 36 |
| 2023 November | 23 | 27 | 50 |
| 2023 October | 18 | 29 | 47 |
| 2023 September | 19 | 31 | 50 |
| 2023 August | 9 | 15 | 24 |
| 2023 July | 16 | 9 | 25 |
| 2023 June | 20 | 22 | 42 |
| 2023 May | 19 | 17 | 36 |
| 2023 April | 11 | 13 | 24 |
| 2023 March | 12 | 15 | 27 |
| 2023 February | 14 | 14 | 28 |
| 2023 January | 7 | 10 | 17 |
| 2022 December | 17 | 27 | 44 |
| 2022 November | 12 | 19 | 31 |
| 2022 October | 4 | 10 | 14 |
Show all
